Ascendis Pharma A/S (ASND)
Pharmaceutical Preparations
Latest Price
$264.92
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
1.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| STATE STREET CORP | 514.0K | $137.0M | 0.85% | +426.6K | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 225.2K | $60.0M | 0.37% | +91.8K | 2026-06-30 |
| NEUBERGER BERMAN GROUP LLC | 142.7K | $38.0M | 0.24% | +121.7K | 2026-06-30 |
| ODDO BHF ASSET MANAGEMENT SAS | 128.7K | $34.0M | 0.21% | -- | 2026-06-30 |
| Quadrature Capital Ltd | 40.8K | $10.0M | 0.07% | +34.3K | 2026-06-30 |
| DEARBORN PARTNERS LLC | 1.3K | -- | 0.00% | -- | 2026-06-30 |
| E Fund Management (Hong Kong) Co., Ltd. | 84 | -- | 0.00% | +24 | 2026-06-30 |
| Ninepoint Partners LP | 26 | -- | 0.00% | -5.4K | 2026-06-30 |
| IFP Advisors, Inc | 14 | -- | 0.00% | -- | 2026-06-30 |
| HUNTINGTON NATIONAL BANK | 1 | -- | 0.00% | -- | 2026-06-30 |